Superior Planning, LLC’s Mirum Pharmaceuticals MIRM Stock Holding History

Superior Planning, LLC’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.8K	Buy	+208	New	+$21.7K	0.01%	733

Other funds holding MIRM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return

Superior Planning, LLC's MIRM Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2026: 208 shares worth $17.8K. The stake represents 0.01% of the portfolio and ranks #733 among its holdings.

187 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

Superior Planning, LLC held 208 shares of Mirum Pharmaceuticals worth $17.8K as of Q3 2026.
Mirum Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Mirum Pharmaceuticals made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #733 holding.
187 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.